Low-molecular-weight heparin (LMWH) was the preferred agent for thromboprophylaxis in critically ill patients. There was considerable variation in the application of LMWH for prophylaxis, reflected by the use of different types, doses, and dosing strategies.

Most physicians would be willing to participate in an RCT on thromboprophylaxis.

A total of 715 physicians from 170 ICUs in 23 countries contributed information, with a mean response rate of 36%.

In most ICUs, both pharmacological (n = 166, 98%) and mechanical thromboprophylaxis (n = 143, 84%) were applied.

A total of 36 pharmacological thromboprophylaxis regimens were reported.

Read More